G. Stojanovic

机构：University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina

发表论文 3 篇 · 总被引 1 次 · h-index 1

代表论文

• 161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) (2023 · Journal of Thoracic Oncology · 被引 1)
• Independent Predictors Associated with Patient Refusal of Invasive Diagnostic Procedures After Positive LDCT Lung Cancer Screening (2026 · Diagnostics)
• P2.15.06 Best Practices and Process Variations of Lung Cancer Multi-Disciplinary Teams: Insights From Europe and Israel (2025 · Journal of Thoracic Oncology)